Display Settings:

Format

Send to:

Choose Destination
    Vaccine. 2010 Aug 23;28(37):5952-9. Epub 2010 Jul 8.

    Economics of employer-sponsored workplace vaccination to prevent pandemic and seasonal influenza.

    Source

    Applied Modeling, Public Health Computational and Operations Research, University of Pittsburgh, Pittsburgh, PA 15213, USA. BYL1@pitt.edu

    Abstract

    Employers may be loath to fund vaccination programs without understanding the economic consequences. We developed a decision analytic computational simulation model including dynamic transmission elements that estimated the cost-benefit of employer-sponsored workplace vaccination from the employer's perspective. Implementing such programs was relatively inexpensive (<$35/vaccinated employee) and, in many cases, cost saving across diverse occupational groups in all seasonal influenza scenarios. Such programs were cost-saving for a 20% serologic attack rate pandemic scenario (range: -$15 to -$995) per vaccinated employee) and a 30% serologic attack rate pandemic scenario (range: -$39 to -$1,494 per vaccinated employee) across all age and major occupational groups.

    Copyright 2010 Elsevier Ltd. All rights reserved.

    PMID:
    20620168
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC2926133
    Free PMC Article

    Images from this publication.See all images (1) Free text

    Figure 1

      Supplemental Content

      Icon for Elsevier Science Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk